baber/WOPTO huggingface dataset:
Patent NZ-246624-A (NZ)
Title: Sulphur-containing 11-substituted 19-nor steroids and medicaments
Inventor: CLAUSSNER ANDRE
IPC: A61K31/585
Filed: 1992-12-17
Abstract: Compounds of formula (I), wherein R17 and R'17 are such that: either R17 and R'17 together form ketone, hydrazono, oxime or methylene, or R17 is hydroxyl, hydroxymethyl or acyloxy and R'17 is hydrogen, alkyl or optionally substitued alkenyl or alkynyl; R3 is hydrogen or alkyl; R16 is hydrogen, halogen or alkyl; m is 0, 1 or 2; X, Y and Z are such that: X is methylene, arylene or arylenoxy bonded to the steroid by a carbon atom; Y is a saturated or unsaturated straight or branched aliphatic chain which is optionally interrupted by oxygen; and Z is aryl, arylalkyl or straight or branched alkyl; addition salts thereof, a preparation method therefor, medicinal uses thereof, compositions containing said compounds, and resulting novel intermediates.
Patent NZ-262190-A (NZ)
Title: Simulated wood product of extrusion or injection moulded cellulosic powder, smaller harder particles, resin and pigment
Inventor: KAMITE MASAYUKI
IPC: B29C48/07
Filed: 1994-03-04
Abstract: The invention relates to a method of manufacturing a wood-like product and the wood-like product which is similar to wood in touch and presents a grain similar to that of natural wood depending upon a molding condition. More specifically, a crushed powder (102) obtained by crushing a cellulose material as a raw material is ground into powder (111, 121) having an increased bulk density. Fixed to the outher peripheral surface of the powder (111, 121) are surface grains (112, 122) each having a smaller diameter and a greater hardness than those of the powder (111, 121) to provide fixing grains (110, 120) which in turn are mixed with resin and pigment to be melted. Thereafter or concurrently with the melting, the grains (110, 120) are formed into a desired shape by extrusion molding or injection molding. <IMAGE>
Patent NZ-270255-A (NZ)
Title: Vinyl aminocarboxylic acid derivatives and pesticidal compositions
Inventor: MAIENFISCH PETER
IPC: C07C69/65
Filed: 1994-12-22
Abstract: Compounds of the formula <CHEM>  wherein   R1   is C3-C8cycloalkyl, halo-C3-C8cycloalkyl, C3-C8cycloalkyl-C1-C6alkyl, halo-C3-C8cycloalkyl-C1-C6alkyl, -Si(R3)3, -S-R4, -SO2-R6 or -CO-R9; R2   is halogen, C1-C4alkyl or CF3, the substituents R2 being identical or different when n is 2; R3   each independently of the others is C1-C6alkyl, haloC1-C6alkyl, C1-C6alkoxy or phenyl; R4   is aryl or heteroaryl each of which is unsubstituted or substituted; R6   is unsubstituted or substituted C1-C10alkyl, C2-C6alkenyl, C2-C6alkynyl, C1-C20alkoxy, C2-C6alkenyloxy, C2-C6alkynyloxy, C1-C4alkylthio, aryl, aryloxy or arylthio, or is optionally substituted amino; R9   is hydroxy, unsubstituted or substituted C1-C10alkyl, C2-C6alkenyl, C2-C6alkynyl, C3-C8cycloalkyl, aryl or aryloxy, or is optionally substituted amino; R12   is hydrogen or unsubstituted or substituted C1-C10-alkyl; m   is 1, 3, 5, 7, 9 or 11; n   is 0, 1 or 2; X   is fluorine or chlorine; and Y   is hydrogen, fluorine or methyl; in free form or in salt form, can be used as pesticides and can be prepared in a manner known per se.
Patent NZ-271332-A (NZ)
Title: Vitamin D analogues and pharmaceutical use
Inventor: BOUILLON ROGER
IPC: C07C47/347
Filed: 1994-07-07
Abstract: The vitamin D analogues of general formula I may be used in pharmaceuticals for treating immunodisorders, inflammatory diseases, skin disorders such as psoriasis, and hyperproliferative disorders such as cancer. In formula I; Pairs of R1, R2, R'2, R'3, R4, R'4, R5 and R'5, may be taken together to form carbocyclic 5- or 6-membered rings as depicted in formulae IIIa1, IIIa2, IIIb1, IIIb2, IIIc1, IIIc2, IIId1, IIId2, IIIe1, IIIe2, IIIf1, IIIf2, IIIf3 and IIIf4; P is H, alkyl or acyl, Y and Y', and W and W' are H, alkyl, or taken together form an alkylidene group or a carbocyclic ring; and X is optionally substituted C2-15 alkyl.
Patent NZ-280098-A (NZ)
Title: Potentiation of immune response using an 1h-imidazo [4,5-c]quinoline-4-amine as adjuvant
Inventor: MILLER RICHARD L
IPC: A61K39/02
Filed: 1993-04-08
Abstract: An immunogen/vaccine adjuvant composition containing an immunogen in an amount effective to stimulate an immune response and as a vaccine adjuvant a 1H-imidazo[4,5-c]quinolin-4-amine in an amount effective to increase the immune response to the immunogen.
Patent NZ-290426-A (NZ)
Title: N-substituted 3-azabicyclo-(3.2.0)heptane derivatives, neuroleptic medicaments
Inventor: STEINER GERD
IPC: C07D403/06
Filed: 1995-07-21
Abstract: PCT No. PCT/EP95/02893 Sec. 371 Date Sep. 18, 1997 Sec. 102(e) Date Sep. 18, 1997 PCT Filed Jul. 21, 1995 PCT Pub. No. WO96/04272 PCT Pub. Date Feb. 15, 1996N-substitued 3-azabicyclo[3.2.0]heptane derivatives of formula (I) in which R1, R2, A, X, Y and Z have the meanings given in the description, their method of preparation and their use as pharmacological agents.
Patent NZ-301518-A (NZ)
Title: Recombinases that can promote homologous recombination in eukaryotic cells
Inventor: HOLLOMAN WILLIAM K
IPC: C12N9/00
Filed: 1996-01-16
Abstract: The specification describes genes encoding recombinases that can be used to promote homologous recombination in eukaryotic cells.  The recombinase has a modified p34cd32 kinase consensus phosphorylation site.  Methods by which a recombinase of one species can be used to isolate a homologous recombinase of a different species and methods to identify the isolated homologs are also described. Recombinases from Ustilago maydis and  Saccharomyces cerevisiae are specifically included.
Patent NZ-312375-A (NZ)
Title: Reclosable storage bag
Inventor: FOWLER DWIGHT P
IPC: B65D33/16
Filed: 1996-06-21
Abstract: reclosable bag (100) includes a detachable reclosure tie (110) having a tail portion (120) formed by a series of spaced elongated seals (116, 117) and a closed loop (121).  Apparatus for forming the reclosure tie with a bag includes first and second sealing jaws (150) with external (153, 155) and internal grippers (162L, 162R, 163L, 163R) for holding web material (151).  The first sealing jaw carries cutting and perforating knives (157, 160) and a cooling block (165L) that directs cooling air onto the knives to prevent the knife temperature from rising to the melting temperature of the web material.  Each sealing jaw contains a heating block (164L, 164R) with complementary sealing surfaces (104R, 105R) for forming various seals including the seals that form the tail portion of the reclosure tie.
Patent NZ-324101-A (NZ)
Title: Protease inhibitors, pharmaceutical compositions and use thereof
Inventor: CARR THOMAS JOSEPH
IPC: C07D277/56
Filed: 1996-10-30
Abstract: Compounds which inhibit proteases, including cathepsin K and  pharmaceutical compositions of such compounds are claimed.  These compounds are hydrazidyl, bis-hydrazidyl, and bis-aminomethyl carbonyls which have the shape to fit and bind to the ezymatic site and to react with a sulfhydryl group on the active site to block the site. These compositions are particularly suitable for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease.
Patent NZ-333431-A (NZ)
Title: Multiple epitope fusion protein selected from HIV or HCV, method of immunoassay and assay device
Inventor: VALENZUELA PABLO D T
IPC: C12P21/04
Filed: 1997-05-23
Abstract: A multiple copy epitope sequence comprising the general structure  [A]x-[B]y-[C]z			Formula 1  Where 1 is a linear amino acid sequence; B is an amino acid sequence containing at least five not more than 1,000 amino acids which amino acids correspond to a naturally occurring antigenic determinant of an organism; A and C are each amino acid sequences different from B and each other and are each independently an amino acid sequence containing at least five not more than 1,000 amino acids represent an antigenic determinant that is not adjacent to B in nature; y is 2 or more and at least one B is either an equivalent antigenic determinant from a different strain of the organism or is an epitope from the same strain of organism; x and z are integers wherein x+z is one or more, and further wherein A,B, and C are epitopes from an organism selected from the groups consisting of human immunodeficiency virus (HIV) and hepatitis C virus (HVC). Further claims is a method for producing an immunoassay where the nucleotide encoding the epitope is placed into an expression cassette, transforming a suitable host with the cassette, purifying the expressed epitope and modifying the epitope for immunoassay.
Patent NZ-333771-A (NZ)
Title: Wallet size credit card book comprising a plurality of leaves and a pocket
Inventor: EXLINE WILLIAM B
IPC: B42D1/00
Filed: 1996-07-09
Abstract: A wallet size card book 10 comprises a cover 12 having a fold which divides the cover into a front 16 and rear 20 panel, a plurality of leaves 22, and a pocket 30.  The pocket is formed by a first leaf being sealed to the inner surface of the cover and cut shorter and narrower than the cover, and a second leaf being sealed along two edges of the inner surface of the cover.  The pocket may be formed by the second leaf being sealed along two edges to an L-shaped glue strip extending along two edges of the inner surface of the cover with a third edge attached at the fold and a fourth edge remaining open.
Patent NZ-335655-A (NZ)
Title: Packaging for smoking articles with a re-sealable or tacky surface
Inventor: BRAY ANDREW JONATHAN
IPC: B65D75/58
Filed: 1997-11-19
Abstract: A cuboid pack of smoking articles having two major faces, two side walls and two end walls, the pack including a sealed enclosure of a layer of barrier material around a charge of the smoking articles, openable edges of an access aperture being defined in the barrier material layer to extend from one end wall into major face of the pack and there being over the aperture and extending beyond all of the defined openable edges a cover layer having a permanently tacky surface engageable with the barrier material layer adjacent to the openable edges of the aperture whereby after opening of the aperture the enclosure may be resealed by re-engaging the permanently tacky surface with the barrier material layer adjacent to those edges.
Patent NZ-337367-A (NZ)
Title: Use of an anode comprising natural or refined sugar as a binding agent in the manufacture of aluminium
Inventor: DUARTE DE CARVALHO JOSE RICARD
IPC: C25C3/12
Filed: 1999-08-20
Abstract: Natural or refined sugar such as brown sugar, demerara sugar, VHP, crystal sugar, refined or hard sugar is used as the binding agent for the components of the anode used in the electrolytic production of primary aluminum. Addition to 337367
Patent NZ-500045-A (NZ)
Title: Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
Inventor: BIHOVSKY RON
IPC: C07K5/065
Filed: 1998-04-15
Abstract: The present invention is directed to novel peptidyl-2-amino-1-hydroxyalkanesulfonic acid inhibitors of cysteine proteases. Methods for the use of the protease inhibitors are also described.
Patent NZ-505449-A (NZ)
Title: A method for increasing or maintaining the yield or concentration of milk protein or milk from a lactating mammal by administering to the mammal a compound that supresses milk fat synthesis
Inventor: MACKLE TIM
IPC: A23C9/20
Filed: 2000-06-28
Abstract: Described is an exvivo cell system for use in vivo expression of an interferon-beta protein, the system comprising: a cell of a mammal; and a vector contained therein having an interferon beta polynucleotide sequence for encoding interferon beta protein and allowing its expression.
Patent NZ-507187-A (NZ)
Title: Aryloxy or heteroaryloxy substituted sulfonamide derivatives useful as matrix metalloproteinase inhibitors
Inventor: TANZAWA KAZUHIKO
IPC: A61K31/18
Filed: 1999-04-02
Abstract: A sulphonamide derivative of formula (I) or a pharmacologically acceptable salt, ester or amide derivative thereof are useful in preventing or treating arthritis or for inhibiting metastasis, invasion or growth of cancer wherein: R1 is hydroxy or hydroxyamino; R2 is hydrogen, optionally substituted alkyl, cycloalkyl or -A-R6 A is alkylene or alkylene interrupted by an oxygen atom, -S(O)m- or -N(R9)-; R6 has the formula (II), (III) or (IV); X is oxygen, a sulphur, -N(R10)- or -C(R11)(R12)-; Y is oxygen, carbonyl, -S(O)n-, -N(R10)- or -C(R11)(R12)-; R7 and R8 are independently hydrogen, carboxyl, halogen, cycloalkyl, haloalkoxy, alkanoyl, haloalkylthio, amino, mono-alkylamino, di-alkylamino, cyano, nitro, optionally substituted aryl, heteroaryl, aryloxy, heteroaryloxy, arylthio, heteroarylthio or an optionally substituted alkyl, alkoxy, alkylthio, alkylsulphinyl or alkylsulphonyl, or R7 and R8 may form, together with the carbon atoms to which they are attached, a substituted non-aromatic hydrocarbon ring, a non-aromatic heterocycle, a non-aromatic hydrocarbon ring or a non-aromatic heterocycle, an optionally substituted aryl ring or a heteroaryl ring. with the proviso that when R7 and R8 are attached to the same carbon atom, R7 and R8 do not form, together with the carbon atom to which they are attached, an optionally substituted aryl ring, a heteroaryl ring; m and n are independently 0, 1 or 2; R9 to R12 are as defined in the specification; R3 is hydrogen atom, optionally substituted alkyl, cycloalkyl, alkenyl or alkynyl; R4 is optionally substituted arylene or heteroarylene;  R5 is optionally substituted alkyl, aryl or heteroaryl; with the proviso that when R2 is hydrogen, optionally substituted alkyl or a cycloalkyl, R3 is an optionally substituted alkynyl.
Patent NZ-525673-A (NZ)
Title: Boat propulsion system with trim plates movable between recessed and extended positions
Inventor: NOYES EVAN L
IPC: B63H5/16
Filed: 2001-10-05
Abstract: A boat propulsion system includes a boat having an elongated hull (154) with a water flow channel (156A,156B) formed in the bottom thereof, wherein movable trim plate or plates (178A, 178B) is disposed within the water flow channel for controlling a flow of water to a surface-piercing propeller (176) which is positioned aft of the water flow channel (156A, 156B) and which is disposed within a propeller cavity (170) formed in the bottom of the hull, and extending upwardly into the hull bottom a greater amount than the deepest portion of the channel. In a fully extended position, the trim plate(s) (178A, 178B) is/are flush with the hull of the boat, and in fully recessed position the trim plate(s) is/are completely recessed within the water flow channel (156A, 156B). The trim plate(s) (178A, 178B) is/are variably movable between the recessed and fully extended positions. This is stated to provide for performance advantages at various boat speeds.
Patent NZ-525754-A (NZ)
Title: Use of rosuvastatin (ZD-4522) in the treatment of heterozygous familial hypercholesterolemia
Inventor: RAZA ALI
IPC: A61K31/505
Filed: 2001-11-16
Abstract: A method for the treatment of heterozygous familial hypercholesterolemia by administering the compound (E)-7-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof.
Patent NZ-527138-A (NZ)
Title: 3-(3-amidinophenyl)-5-[({[1-(1-(-iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
Inventor: HARA TAKAYUKI
IPC: A61K31/445
Filed: 2002-01-28
Abstract: Crystal of 3-(3-amidinophenyl)-5-[({[1-(1-imiinoethyl)-4-piperidyl]methyl}amino)methyl] benzoic acid dihydrochloride hydrate, which shows main peaks at a diffraction angle of 2è (0) of 12.2, 13.5, 16.5, 18.5, 19.2, 20.5, 22.0, 22.8, 23.6, 24.7, 25.1, 25.5, 26.1, 29.8, 33.1 and 33.7 in powder in X-ray diffractometry. A process for the production of the crystal of 3-(3-amidinophenyl)-5-[({[1-(1-imiinoethyl)-4-piperidyl]methyl}amino)methyl] benzoic acid dihydrochloride hydrate described above is exemplified. The process comprises reacting methyl 3-(3-amidinophenyl)-5-({[(4-piperidyl) methyl] amino} methyl) benzoate (represented by formula (II)) with ethylacetoinidate HCl to form methyl 3-(3-amidinophenyl)-5-[ ({ [1-(1-iminoethyl)-4-piperidyl]methyl} amino)methyl]benzoate (represented by formula (III) where x represents 0 to 3).
Patent NZ-528372-A (NZ)
Title: Flotation machine
Inventor: NIITTI TIMO
IPC: B03D1/14
Filed: 2002-04-03
Abstract: Disclosed is a flotation machine, particularly to a flotation machine rotor, that is used for dispersing air, supplied via the rotor axis, to the surrounding slurry, and in which rotor there are formed alternating air ducts and slurry grooves, so that the end of both the air ducts and the slurry grooves, projecting outwardly from the rotor, form the outer surface of the rotor. According to the invention the air ducts 3 are arranged in the rotor at essentially equal distances, starting radially from the rotor outer surface, so that the air ducts 3 form in the center part of the rotor a space 6 for the slurry, in which space the slurry surrounding the rotor is to be made to flow along the slurry grooves 5 provided in between the air ducts 3.
Patent NZ-528783-A (NZ)
Title: Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
Inventor: COHEN IRUN R
IPC: A61K47/48
Filed: 2002-04-11
Abstract: Disclosed herein is a use of a carrier which is an anti-inflammatory immunomodulator selected from: (a) a saturated or cis-unsaturated C10-C20 fatty alcohol or an ester thereof with a C1-C6 alkanoic acid; and (b) a saturated or cis-unsaturated C10-C20 fatty acid ester selected from a C1-C6 alkyl ester, a monoester with a C2-C6 polyol having a least two hydroxy groups, and a diester with glycerol, together with an antigen recognized by inflammatory T-cells associated with the pathogenesis of a T-cell mediated disease or condition, for the manufacture of a therapeutic preparation for the treatment of said T-cell mediated disease or condition. The T-cell mediated disease or condition include organ-specific autoimmune disease selected from type I diabetes, multiple sclerosis, rheumatoid arthritis and autoimmune thyroiditis
Patent NZ-528921-A (NZ)
Title: Improvements in and relating to multifold door and window assemblies
Inventor: GLOVER MICHAEL FREDERICK
IPC: E05D7/081
Filed: 2003-10-14
Abstract: A multi-fold leaf (30, 31) joinery assembly has a joinery bogey unit (2) that is pivotally connected to a joinery leaf. A seal (20) is provided on a moveable edge of the leaf adjacent to the bogey unit, the seal being adjacent to a frame seal (25) for a head or sill of a frame of the assembly when the at least one leaf is in a closed position. The pivot connection is off-set so that the seal moves away from the frame seal when the leaf is opened, thus avoiding scrubbing.
Patent NZ-529782-A (NZ)
Title: Roadway paving system and method including roadway paving vehicle and supply truck
Inventor: BARNAT JAMES J
IPC: E01C19/21
Filed: 2002-05-28
Abstract: A roadway paving system for chipsealing a roadway surface comprising a novel roadway paving vehicle and a novel supply truck is provided. The roadway paving vehicle comprises an asphalt binder material dispensing system and an aggregate material dispensing system. The asphalt binder material dispensing system includes an asphalt tank and a sprayer that sprays a first layer of the asphalt binder material over the roadway surface. The aggregate material dispensing system comprises an aggregate hopper and conveyor mechanism that discharges a second layer of aggregate material over the roadway surface. No wheels run over a freshly laid surface. Supply trucks are linked to the roadway paving vehicle to refill the roadway paving vehicle on a continuous basis without the need of stopping the vehicle.
Patent NZ-530314-A (NZ)
Title: Benzo [G] quinoline derivatives for treating glaucoma and myopia
Inventor: MARKSTEIN RUDOLF
IPC: A61P27/06
Filed: 2002-07-08
Abstract: Described is the compound of formula I wherein: A and B are each H or form together an additional bond; X is CH2 or CO Y is O, S, NR2, [R2 being H or (C1-4)alkyl], CH2 or O-CH2; and R1 is H or (C1-4)alkyl; in free base or acid addition salt form. Pharmaceutical compositions comprising the compound are useful for treating myopia and glaucoma.
Patent NZ-533297-A (NZ)
Title: Forming a RTP (real time transport protocol) payload format for streaming audio video media over a network
Inventor: ALKOVE JAMES M
IPC: H04L47/43
Filed: 2004-06-02
Abstract: A data stream is encrypted to form encryption units that are packetized into RTP packets. Each RTP packet includes an RTP packet header, one or more payloads of a common data stream, and a RTP payload format header for each payload and including, for the corresponding encryption units, a boundary for the payload. The payload can be one or more of the encryption units or a fragment of one of the encryption units. The encryption units are reassembled the using the payloads in the RTP packets and the respective boundary in the respective RTP payload format header. The reassembled of encryption units are decrypted for rendering. Each RTP payload format header can have attributes for the corresponding payload that can be used to render the payload. The RTP packets can be sent server-to-client or peer-to-peer.
Patent NZ-545086-A (NZ)
Title: Pharmaceutical compositions and methods for accelerating wound healing
Inventor: SOLOMONIK INESSA
IPC: A61K/
Filed: 2004-08-05
Abstract: Provided is the use of a compound selected from the group consisting of adipsin, adiponectin, resistin, lipoprotein lipase, angiotensinogen, angiotensin like 4, matrix metalloproteinase 2, matrix metalloproteinase 9, and a PPAR- gamma antagonist for the preparation of a pharmaceutical composition adapted for topical application for inducing or accelerating a healing process of a skin wound. Further provided is the use of adipocytes, preadipocytes or non-totipotent stem cells, for the preparation of a pharmaceutical composition adapted for implantation into a skin wound for inducing or accelerating a healing process of the skin wound, wherein said adipocytes or preadipocytes and non-totipotent stem cells have been previously exposed to the said compound.
Patent NZ-549254-A (NZ)
Title: Amido-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
Inventor: SCHMIDT BEATE
IPC: C07D471/04
Filed: 2005-03-09
Abstract: Disclosed is 6-phenyl-phenanthridine as represented by formula I, in which R1 and R2 are each independently alkoxy, 2,2-difluoroethoxy, or completely or predominantly fluorine-substituted alkoxy, R3 is hydrogen, R31 is hydrogen, R4 is -OH, R5 is hydrogen, R6 is hydrogen, R7 is -N(R8)R9 or -NH-N(R18)R19, and wherein the other substituents are as defined herein. Further disclosed is the use of a compound as defined above for the production of a pharmaceutical composition for treating bronchial asthma, COPD, atopic eczema, psoriasis, or diabetes mellitus.
Patent NZ-549851-A (NZ)
Title: Columnar air moving fan to avoid de-stratification using guides spaced from impeller
Inventor: AVEDON RAYMOND B
IPC: F04D29/54
Filed: 2005-02-28
Abstract: Air moving device includes a housing, an impeller in the housing for generating a downward air flow, and vanes in the housing in close proximity to and a selected distance below the impeller to straighten the air flow. The device produces an air flow that substantially remains in a column over a substantial distance. The method includes producing an air flow that substantially remains in a column over a substantial distance and directing the air flow from the ceiling towards the floor to provide temperature destratification of the air in an enclosed space. The method also includes directing warm air from the ceiling to the floor and storing heat in the floor, apparatus on the floor and storing heat in the floor. The stored heat is released when the ceiling is cooler than the floor.